All Stories

  1. Structural characterization of human monoclonal antibodies targeting uncommon antigenic sites on spike glycoprotein of SARS-CoV

    Article • Journal of Clinical Investigation, November 2024, American Society for Clinical Investigation

    Dr Robert H Carnahan

  2. Protective threshold of a potent neutralizing Zika virus monoclonal antibody in rhesus macaques

    Article • August 2024, Cold Spring Harbor Laboratory Press

    Dr Robert H Carnahan

  3. Functional and structural basis of human parainfluenza virus type 3 neutralization with human monoclonal antibodies

    Article • Nature Microbiology, June 2024, Springer Science + Business Media

    Dr Robert H Carnahan

  4. Potent HPIV3-neutralizing IGHV5-51 Antibodies Identified from Multiple Individuals Show L Chain and CDRH3 Promiscuity

    Article • The Journal of Immunology, March 2024, The American Association of Immunologists

    Dr Robert H Carnahan

  5. Data from Development of an Anti-canine PD-L1 Antibody and Caninized PD-L1 Mouse Model as Translational Research Tools for the Study of Immunotherapy in Humans

    Article • May 2023, American Association for Cancer Research (AACR)

    Dr Robert H Carnahan

  6. Data from Development of an Anti-canine PD-L1 Antibody and Caninized PD-L1 Mouse Model as Translational Research Tools for the Study of Immunotherapy in Humans

    Article • May 2023, American Association for Cancer Research (AACR)

    Dr Robert H Carnahan

  7. FIGURE 1 from Development of an Anti-canine PD-L1 Antibody and Caninized PD-L1 Mouse Model as Translational Research Tools for the Study of Immunotherapy in Humans

    Article • May 2023, American Association for Cancer Research (AACR)

    Dr Robert H Carnahan

  8. FIGURE 1 from Development of an Anti-canine PD-L1 Antibody and Caninized PD-L1 Mouse Model as Translational Research Tools for the Study of Immunotherapy in Humans

    Article • May 2023, American Association for Cancer Research (AACR)

    Dr Robert H Carnahan

  9. FIGURE 2 from Development of an Anti-canine PD-L1 Antibody and Caninized PD-L1 Mouse Model as Translational Research Tools for the Study of Immunotherapy in Humans

    Article • May 2023, American Association for Cancer Research (AACR)

    Dr Robert H Carnahan

  10. FIGURE 2 from Development of an Anti-canine PD-L1 Antibody and Caninized PD-L1 Mouse Model as Translational Research Tools for the Study of Immunotherapy in Humans

    Article • May 2023, American Association for Cancer Research (AACR)

    Dr Robert H Carnahan

  11. FIGURE 3 from Development of an Anti-canine PD-L1 Antibody and Caninized PD-L1 Mouse Model as Translational Research Tools for the Study of Immunotherapy in Humans

    Article • May 2023, American Association for Cancer Research (AACR)

    Dr Robert H Carnahan

  12. FIGURE 3 from Development of an Anti-canine PD-L1 Antibody and Caninized PD-L1 Mouse Model as Translational Research Tools for the Study of Immunotherapy in Humans

    Article • May 2023, American Association for Cancer Research (AACR)

    Dr Robert H Carnahan

  13. FIGURE 4 from Development of an Anti-canine PD-L1 Antibody and Caninized PD-L1 Mouse Model as Translational Research Tools for the Study of Immunotherapy in Humans

    Article • May 2023, American Association for Cancer Research (AACR)

    Dr Robert H Carnahan

  14. FIGURE 4 from Development of an Anti-canine PD-L1 Antibody and Caninized PD-L1 Mouse Model as Translational Research Tools for the Study of Immunotherapy in Humans

    Article • May 2023, American Association for Cancer Research (AACR)

    Dr Robert H Carnahan

  15. FIGURE 5 from Development of an Anti-canine PD-L1 Antibody and Caninized PD-L1 Mouse Model as Translational Research Tools for the Study of Immunotherapy in Humans

    Article • May 2023, American Association for Cancer Research (AACR)

    Dr Robert H Carnahan

  16. FIGURE 5 from Development of an Anti-canine PD-L1 Antibody and Caninized PD-L1 Mouse Model as Translational Research Tools for the Study of Immunotherapy in Humans

    Article • May 2023, American Association for Cancer Research (AACR)

    Dr Robert H Carnahan

  17. FIGURE 6 from Development of an Anti-canine PD-L1 Antibody and Caninized PD-L1 Mouse Model as Translational Research Tools for the Study of Immunotherapy in Humans

    Article • May 2023, American Association for Cancer Research (AACR)

    Dr Robert H Carnahan

  18. FIGURE 6 from Development of an Anti-canine PD-L1 Antibody and Caninized PD-L1 Mouse Model as Translational Research Tools for the Study of Immunotherapy in Humans

    Article • May 2023, American Association for Cancer Research (AACR)

    Dr Robert H Carnahan

  19. TABLE 1 from Development of an Anti-canine PD-L1 Antibody and Caninized PD-L1 Mouse Model as Translational Research Tools for the Study of Immunotherapy in Humans

    Article • May 2023, American Association for Cancer Research (AACR)

    Dr Robert H Carnahan

  20. TABLE 1 from Development of an Anti-canine PD-L1 Antibody and Caninized PD-L1 Mouse Model as Translational Research Tools for the Study of Immunotherapy in Humans

    Article • May 2023, American Association for Cancer Research (AACR)

    Dr Robert H Carnahan

  21. Table S1 from Development of an Anti-canine PD-L1 Antibody and Caninized PD-L1 Mouse Model as Translational Research Tools for the Study of Immunotherapy in Humans

    Article • May 2023, American Association for Cancer Research (AACR)

    Dr Robert H Carnahan

  22. Table S1 from Development of an Anti-canine PD-L1 Antibody and Caninized PD-L1 Mouse Model as Translational Research Tools for the Study of Immunotherapy in Humans

    Article • May 2023, American Association for Cancer Research (AACR)

    Dr Robert H Carnahan

  23. Development of an anti-canine PD-L1 Antibody and Caninized PD-L1 Mouse Model as Translational Research Tools for the Study of Immunotherapy in Humans

    Article • Cancer Research Communications, May 2023, American Association for Cancer Research (AACR)

    Dr Robert H Carnahan

  24. De novo sequencing and construction of a unique antibody for the recognition of alternative conformations of cytochrome c in cells

    Article • Proceedings of the National Academy of Sciences, November 2022, Proceedings of the National Academy of Sciences

    Professor Rafael Radi, Dr Robert H Carnahan

  25. Real-time cell analysis: A high-throughput approach for testing SARS-CoV-2 antibody neutralization and escape

    Article • STAR Protocols, April 2022, Elsevier

    Dr Robert H Carnahan

  26. Neutralizing antibodies protect mice against Venezuelan equine encephalitis virus aerosol challenge

    Article • Journal of Experimental Medicine, March 2022, Rockefeller University Press

    Dr Robert H Carnahan

  27. Neutralization Fingerprinting Technology for Characterizing Polyclonal Antibody Responses to Dengue Vaccines

    Article • December 2021, Cold Spring Harbor Laboratory Press

    Dr Robert H Carnahan

  28. Human antibody recognition of H7N9 influenza virus hemagglutinin following natural infection

    Article • JCI Insight, August 2021, American Society for Clinical Investigation

    Dr Robert H Carnahan

  29. Protective pan-ebolavirus combination therapy by two multifunctional human antibodies

    Article • May 2021, Cold Spring Harbor Laboratory Press

    Dr Robert H Carnahan

  30. A Requirement for p120-catenin in the metastasis of invasive ductal breast cancer

    Article • Journal of Cell Science, October 2020, The Company of Biologists

    Dr Robert H Carnahan

  31. Multifunctional Pan-ebolavirus Antibody Recognizes a Site of Broad Vulnerability on the Ebolavirus Glycoprotein

    Article • Immunity, July 2018, Elsevier

    Dr Robert H Carnahan, Dr James E Crowe

  32. p120-Catenin is an obligate haploinsufficient tumor suppressor in intestinal neoplasia

    Article • Journal of Clinical Investigation, November 2017, American Society for Clinical Investigation

    Dr Robert H Carnahan

  33. Characterizing Antibodies

    Article • Cold Spring Harbor Protocols, November 2017, Cold Spring Harbor Laboratory Press

    Dr Robert H Carnahan

  34. Isotype Determination of Rodent-Derived Monoclonal Antibodies Using Sandwich ELISA

    Article • Cold Spring Harbor Protocols, November 2017, Cold Spring Harbor Laboratory Press

    Dr Robert H Carnahan

  35. Using Small Case-Based Learning Groups as a Setting for Teaching Medical Students How to Provide and Receive Peer Feedback

    Article • Medical Science Educator, September 2017, Springer Science + Business Media

    Dr Robert H Carnahan

  36. Structural Insights into Reovirus σ1 Interactions with Two Neutralizing Antibodies

    Article • Journal of Virology, December 2016, ASM Journals

    Dr Robert H Carnahan

  37. Anti-MTG16 antibodies reveal MTG16 subcellular distribution and nucleocytoplasmic transport in erythroleukemia cells

    Article • Antibody Technology Journal, February 2015, Taylor & Francis

    Dr Robert H Carnahan, Dr Michael Eugene Engel

  38. Kaiso Directs the Transcriptional Corepressor MTG16 to the Kaiso Binding Site in Target Promoters

    Article • PLoS ONE, December 2012, PLOS

    Dr Robert H Carnahan

  39. Monoclonal Antibodies to DIPA: A Novel Binding Partner of p120-Catenin Isoform 1

    Article • August 2012, Mary Ann Liebert Inc

    Dr Robert H Carnahan

  40. p120-catenin is essential for terminal end bud function and mammary morphogenesis

    Article • Development, March 2012, The Company of Biologists

    Dr Robert H Carnahan

  41. Selection of Monoclonal Antibodies Against 6-oxo-M 1 dG and Their Use in an LC-MS/MS Assay for the Presence of 6-oxo-M 1 dG in Vivo

    Article • Chemical Research in Toxicology, February 2012, American Chemical Society (ACS)

    Dr Robert H Carnahan

  42. Faculty Opinions recommendation of Zeppo1 is a novel metastasis promoter that represses E-cadherin expression and regulates p120-catenin isoform expression and localization.

    Article • August 2011, F1000Research

    Dr Robert H Carnahan

  43. Abstract 4157: Identification and validation of galectin-7 as a novel blood biomarker for NSCLC diagnosis

    Article • Cancer Research, April 2011, American Association for Cancer Research (AACR)

    Dr Robert H Carnahan

  44. ReCLIP (Reversible Cross-Link Immuno-Precipitation): An Efficient Method for Interrogation of Labile Protein Complexes

    Article • PLoS ONE, January 2011, PLOS

    Dr Robert H Carnahan

  45. The Molecular Evolution of the p120-Catenin Subfamily and Its Functional Associations

    Article • PLoS ONE, December 2010, PLOS

    Dr Robert H Carnahan, Professor Antonis Rokas

  46. Faculty Opinions recommendation of Heterozygous deficiency of delta-catenin impairs pathological angiogenesis.

    Article • September 2010, F1000Research

    Dr Robert H Carnahan

  47. Faculty Opinions recommendation of Dynamic and static interactions between p120 catenin and E-cadherin regulate the stability of cell-cell adhesion.

    Article • May 2010, F1000Research

    Dr Robert H Carnahan

  48. Faculty Opinions recommendation of Plakophilin 1 stimulates translation by promoting eIF4A1 activity.

    Article • March 2010, F1000Research

    Dr Robert H Carnahan

  49. Faculty Opinions recommendation of Essential role for eIF4GI overexpression in the pathogenesis of inflammatory breast cancer.

    Article • January 2010, F1000Research

    Dr Robert H Carnahan

  50. p120-Catenin and p190RhoGAP Regulate Cell-Cell Adhesion by Coordinating Antagonism between Rac and Rho

    Article • Cell, December 2006, Elsevier

    Dr Robert H Carnahan, Dr Gregg A Wildenberg

  51. p120 serine and threonine phosphorylation is controlled by multiple ligand–receptor pathways but not cadherin ligation

    Article • Experimental Cell Research, October 2006, Elsevier

    Dr Robert H Carnahan, Dr Gregg A Wildenberg

  52. Regulation of cadherin stability and turnover by p120ctn: implications in disease and cancer

    Article • Seminars in Cell and Developmental Biology, December 2004, Elsevier

    Dr Robert H Carnahan

  53. Vectors and gene targeting modules for tandem affinity purification inSchizosaccharomyces pombe

    Article • Yeast, January 2001, Wiley

    Dr Robert H Carnahan